JB
Therapeutic Areas
Cadenza Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| ERβ Modulator Program | Multiple Sclerosis | Preclinical |
Leadership Team at Cadenza Bio
CC
Carol Curtis, PhD
Chief Executive Officer, Founder
EH
Elaine Hamm, PhD
Chief Operating Officer, Founder
DM
David Martin, PharmD, MBA
Chief Development Officer
JK
John Katzenellenbogen, PhD
Scientific Founder
ST
Seema Tiwari-Woodruff, PhD
Scientific Founder